Springer Nature
Browse
13063_2016_1447_MOESM1_ESM.docx (26.15 kB)

Additional file 1: Table S1. of No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals

Download (26.15 kB)
journal contribution
posted on 2016-07-16, 05:00 authored by Nicole Gabler, Naihua Duan, Eli Raneses, Leah Suttner, Michael Ciarametaro, Elizabeth Cooney, Robert Dubois, Scott Halpern, Richard Kravitz
Variables examined for subgroup analysis. Table S2 Use of risk inex for subgroup exploration using appropriate methods. Table S3 RCTs that have a sample size greater than 250 and at least 100 per arm. Table S4 Bivariables associations of trial characteristics and reporting of any exploration of subgroup analysis and reporting of subgroup analysis using appropriate methods among RCTs that have a sample size greater than 250 and at least 100 per arm. (DOCX 26 kb)

Funding

National Pharmaceutical Council

History